We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MP:NYSEMP Materials Corp. Analysis

Data as of 2026-04-18 - not real-time

$60.99

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

MP Materials is trading at $60.99, comfortably above its 20‑day SMA of 53.38 and the 50‑day SMA of 56.82, but still below the 200‑day SMA of 61.80, indicating a mixed technical picture. The RSI of 60.8 suggests modest momentum, while the MACD histogram is positive and the signal line is bearish, producing a bullish MACD signal. Volume is on a decreasing trend, and the 30‑day volatility of 70.6% combined with a beta around 1.3 points to a highly volatile, risk‑on environment. Price sits near the calculated resistance of 64.31 with support at 44.43, and the overall trend is flagged as bearish.
Fundamentally, MP reports negative operating margins and a trailing EPS of –$0.50, yet forward EPS is projected at $1.31, yielding a forward P/E of 46.45 and a price‑to‑book of 5.47. The company holds over $1.8 B in cash against $1.0 B of debt, giving a debt‑to‑equity of roughly 43%. Analysts (13) have a consensus “strong buy” with a median price target of $79, implying ~27% upside. Recent news highlights a strategic push to expand refining capacity to 6,000 tons and reinforces MP’s role in U.S. rare‑earth autonomy, adding a secular growth catalyst despite current earnings weakness.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance with bearish trend direction
  • Decreasing volume and high short‑term volatility
  • Bullish MACD signal offering limited upside

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst consensus strong‑buy and median target of $79
  • Strategic capacity expansion to 6,000 tons
  • Forward earnings visibility with positive EPS forecast

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Secular demand for rare‑earths in EVs and defense
  • U.S. policy support for domestic rare‑earth supply
  • Strong cash position to fund growth despite current losses

Key Metrics & Analysis

Financial Health

Revenue Growth70.00%
Profit Margin-31.18%
P/E Ratio46.5
ROE-4.98%
ROA-2.53%
Debt/Equity43.25
P/B Ratio5.5
Op. Cash Flow$-155755008
Free Cash Flow$-237324752

Technical Analysis

TrendBearish
RSI60.8
Support$44.43
Resistance$64.31
MA 20$53.38
MA 50$56.82
MA 200$61.80
MACDBullish
VolumeDecreasing
Fear & Greed Index90.21

Valuation

Target Price$77.69
Upside/Downside27.39%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta1.30
Volatility70.64%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.